Altenpflege in Europa - ein Zukunftsmarkt?
Eine aktuelle Analyse/Gegenüberstellung beider Unternehmen findet man hier:
https://lerevenu.com/bourse/...-coude-coude-sur-le-marche-de-lor-gris
Was du verlinkst, liest du auch, Manni? Nur nochmal zur Erinnerung, es sind 3 Kapitalerhöhungen mit einer Ausgabe von >13 Milliarden neuen Aktien geplant.
"The company on Monday said that a planned capital increase amid a wider restructuring process would reflect a theoretical share price value of less than 0.20 euros, significantly lower than its current valuation."
P.S.: Du bist zwar aus der hibbeligen Memestock-Generation, aber die Einzeiler-Multipostings könntest du trotzdem etwas zurückfahren.
https://www.undervalued-shares.com/reports/...geing-population/aff/9/
It is also recalled that the current stock price of the ORPEA share (i.e. 0.2254 euro at close on 29 November 2023) remains significantly decorrelated from the subscription price of the New Shares issued in the context of the Equitization Capital Increase (i.e. 0.0601 euro per share) and the theoretical value of the share post-Capital Increases to be carried out under the Accelerated Safeguarding Plan, which is below 0.02 euro per share. It is thus highly probable that the price of the share post-Capital Increases will be close to the issue prices of the Capital Increases (0.0178 euro per share, for the subscription of the 65,173,064,696 new shares to be issued in the context of the Groupement Capital Increase ; 0.0133 euro per share, for the subscription of the 29,324,787,415 new shares to be issued in the context of the Rights Issue), thus implying a massive decline in the share price and significant losses for shareholders who have purchased shares of the Company at a higher price.